SEC Form 4 · accession 0001179110-17-011980
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Craig A Wheeler
Officer — President · Director
Period of report
Aug 31, 2017
Accepted (ET)
Sep 5, 2017 · 3:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Aug 31, 2017 | M | 2,300 | $7.41 | A | 262,754 | D | |
| Common Stock | Aug 31, 2017 | S | 2,300 | $17.00 | D | 260,454 | D | |
| Common StockF3 | Aug 31, 2017 | S | 3,450 | $17.00 | D | 293,088 | I | Craig Wheeler Revocable Trust |
| Common Stock | Sep 1, 2017 | M | 14,167 | $7.41 | A | 274,621 | D | |
| Common StockF4 | Sep 1, 2017 | S | 14,167 | $17.00 | D | 260,454 | D | |
| Common Stock | Sep 1, 2017 | S | 450 | $17.00 | D | 292,638 | I | Craig Wheeler Revocable Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $7.41 | Aug 31, 2017 | M | 2,300 | D | May 22, 2008 | Feb 22, 2018 | Common Stock | 2,300 | 65,500 | D |
| Stock Option (Right to Buy) | $7.41 | Sep 1, 2017 | M | 14,167 | D | May 22, 2008 | Feb 22, 2018 | Common Stock | 14,167 | 51,333 | D |
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2016.
- F2Reflects a decrease of 6,719 shares of MNTA common stock transferred to the Craig Wheeler Revocable Trust on August 29, 2017.
- F3Reflects the transfer of 6,719 shares of MNTA common stock on August 29, 2017 to the Craig Wheeler Revocable Trust that were previously held directly by Mr. Wheeler.
- F4This transaction was executed in multiple trades at prices ranging from $17.00 to $17.025. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.